Search Results
10
Everything
Mama’s Creations to Present at Upcoming Investor Conferences
March 11, 2025 08:31 ET
|
Mama’s Creations, Inc.
Management to Discuss Near-Term Revenue Growth and Margin Expansion Expectations Company Continues to Benefit from Robust Operating Position in Current Economic Climate, Benefitting from Fixed Price...
Immunocore to present at upcoming investor conferences
March 03, 2025 07:00 ET
|
Immunocore Holdings plc
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 03 March 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology...
ITM to Present at Raymond James Private Biotech Symposium
February 18, 2025 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, February 18, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in the Raymond James Private Biotech...
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 07, 2025 08:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, February 7, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in Oppenheimer’s 35th Annual Healthcare...
Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 03, 2025 07:00 ET
|
Chemomab Therapeutics
Chemomab will present at the Oppenheimer Heathcare Life Sciences Conference on Feb 11 at 8 am ET and participate in 1x1 investor meetings.
HydroGraph to Participate in January Investor Conferences
January 14, 2025 07:00 ET
|
Hydrograph Clean Power Inc.
VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”) a sustainable commercial manufacturer of pristine...
ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 13, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 13, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that its Chief Executive Officer, Dr. Andrew...
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
December 03, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab management is participating in the Oppenheimer Movers in Rare Disease Summit on Dec 13, 2024 at the Westin Grand Central in NYC.
AvePoint to Participate in Upcoming Investor Conferences
November 11, 2024 09:00 ET
|
AvePoint, Inc.
JERSEY CITY, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in robust data management and data governance, today announced that members of the Company’s executive...
ITM to Participate in Upcoming Investor Conferences
November 11, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, November 11, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor...